IE47555B1 - Arylpyridazinylhydrazine salt,processes for preparing it and pharmaceutical compositions containing it - Google Patents

Arylpyridazinylhydrazine salt,processes for preparing it and pharmaceutical compositions containing it

Info

Publication number
IE47555B1
IE47555B1 IE1702/78A IE170278A IE47555B1 IE 47555 B1 IE47555 B1 IE 47555B1 IE 1702/78 A IE1702/78 A IE 1702/78A IE 170278 A IE170278 A IE 170278A IE 47555 B1 IE47555 B1 IE 47555B1
Authority
IE
Ireland
Prior art keywords
salt
monohydrate
water
solution
solid
Prior art date
Application number
IE1702/78A
Other languages
English (en)
Other versions
IE781702L (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of IE781702L publication Critical patent/IE781702L/xx
Publication of IE47555B1 publication Critical patent/IE47555B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IE1702/78A 1978-08-04 1978-08-22 Arylpyridazinylhydrazine salt,processes for preparing it and pharmaceutical compositions containing it IE47555B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7832312 1978-08-04

Publications (2)

Publication Number Publication Date
IE781702L IE781702L (en) 1980-02-04
IE47555B1 true IE47555B1 (en) 1984-04-18

Family

ID=10498866

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1702/78A IE47555B1 (en) 1978-08-04 1978-08-22 Arylpyridazinylhydrazine salt,processes for preparing it and pharmaceutical compositions containing it

Country Status (29)

Country Link
EP (1) EP0007930B1 (Direct)
JP (1) JPS6040424B2 (Direct)
AR (1) AR223327A1 (Direct)
AT (1) AT361001B (Direct)
BG (1) BG34335A3 (Direct)
CA (1) CA1098522A (Direct)
CS (1) CS204035B2 (Direct)
DD (1) DD138656A5 (Direct)
DE (1) DE2862214D1 (Direct)
DK (1) DK147761C (Direct)
EG (1) EG13469A (Direct)
ES (1) ES473056A1 (Direct)
FI (1) FI64585C (Direct)
GR (1) GR64897B (Direct)
HU (1) HU181959B (Direct)
IE (1) IE47555B1 (Direct)
IL (1) IL55455A (Direct)
IN (1) IN148775B (Direct)
IT (1) IT1110169B (Direct)
MT (1) MTP851B (Direct)
MX (1) MX5425E (Direct)
NO (1) NO783005L (Direct)
NZ (1) NZ188281A (Direct)
OA (1) OA06046A (Direct)
PL (1) PL119444B1 (Direct)
SU (1) SU897110A3 (Direct)
YU (1) YU209078A (Direct)
ZA (1) ZA785008B (Direct)
ZM (1) ZM8078A1 (Direct)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE42214B1 (en) * 1974-06-18 1980-07-02 Smith Kline French Lab Hydrazinopyredazines

Also Published As

Publication number Publication date
IL55455A (en) 1981-11-30
IE781702L (en) 1980-02-04
YU209078A (en) 1982-10-31
HU181959B (en) 1983-11-28
DK147761C (da) 1985-05-20
SU897110A3 (ru) 1982-01-07
EG13469A (en) 1982-06-30
FI64585C (fi) 1983-12-12
EP0007930B1 (en) 1983-03-30
GR64897B (en) 1980-06-07
AT361001B (de) 1981-02-10
EP0007930A1 (en) 1980-02-20
DE2862214D1 (en) 1983-05-05
IT1110169B (it) 1985-12-23
ES473056A1 (es) 1979-05-01
DD138656A5 (de) 1979-11-14
CS204035B2 (en) 1981-03-31
PL119444B1 (en) 1981-12-31
ZA785008B (en) 1979-08-29
PL209407A1 (Direct) 1980-05-19
DK147761B (da) 1984-12-03
FI64585B (fi) 1983-08-31
OA06046A (fr) 1981-06-30
FI782705A7 (fi) 1980-02-05
IN148775B (Direct) 1981-06-13
MX5425E (es) 1983-08-03
NZ188281A (en) 1980-11-14
ATA638378A (de) 1980-07-15
DK389378A (da) 1980-02-05
MTP851B (en) 1980-06-30
ZM8078A1 (en) 1979-07-19
CA1098522A (en) 1981-03-31
IT7827234A0 (it) 1978-08-31
BG34335A3 (bg) 1983-08-15
AR223327A1 (es) 1981-08-14
JPS5522651A (en) 1980-02-18
NO783005L (no) 1980-02-05
JPS6040424B2 (ja) 1985-09-11

Similar Documents

Publication Publication Date Title
RU2339622C2 (ru) Новые композиции, содержащие хинолиновые соединения
US7838678B2 (en) Process for preparing atazanavir bisulfate and novel forms
CA1238906A (en) Benzofuran- and benzopyran-carboxamide derivatives
JPH04261152A (ja) 新規１−ベンジル−アミノアルキル−ピロリジノン化合物及びその製造方法
EP0058614B1 (en) 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8 naphtyridine-3-carboxylic acid. sesquihydrate, processes for the preparation thereof and use thereof as antibacterial agents
US5739381A (en) Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present
JPS601310B2 (ja) イミダゾリン化合物の製法
JPS6051172A (ja) ピロリジノン誘導体
EP0007930B1 (en) Arylpyridazinylhydrazine salt, processes for preparing it and pharmaceutical compositions containing it.
EP0537532B1 (en) 2,2'-Alkylenediindole derivatives, process for their production, medicines containing them and their use as anti-ulcer agents
US3998953A (en) 1,3,7-Trisubstitued xanthine peripheral vasodilators
JPS58188879A (ja) シプロヘプタジン−３−カルボン酸及び構造的に関連した化合物のエステル
US4139620A (en) 1-Substituted-3-aminoethoxypyrrolidines and use thereof
JP7675647B2 (ja) （ｓ）－ｎ－（３－（（２－（（４－（（１－アセチルピロリジン－３－イル）（メチル）アミノ）フェニル）アミノ）－５－メトキシピリミジン－４－イル）オキシ）フェニル）アクリルアミドの製造のためのプロセスおよびその製剤
GB2074576A (en) 1-(acylamino-aryloxy)-3-alkylamino-propan-2-ols processes for their preparation and pharmaceutical compositions containing them
US3576809A (en) 2-substituted derivatives of 6-methoxyquinoline
JPS59210074A (ja) 新規ピペラジン化合物
JP2023161038A (ja) （ｓ）－ｎ－（３－（（２－（（４－（（１－アセチルピロリジン－３－イル）（メチル）アミノ）フェニル）アミノ）－５－メトキシピリミジン－４－イル）オキシ）フェニル）アクリルアミドの製造のためのプロセスおよびその製剤
WO2025057087A1 (en) Solid state forms of samuraciclib
JP2025071279A (ja) （ｓ）－ｎ－（３－（（２－（（４－（（１－アセチルピロリジン－３－イル）（メチル）アミノ）フェニル）アミノ）－５－メトキシピリミジン－４－イル）オキシ）フェニル）アクリルアミドの製造のためのプロセスおよびその製剤
JPH06506208A (ja) 新規チオフェン−２−カルボン酸誘導体およびそれらの製造法
Rothenberger Gore et a
HK1035717B (en) New crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester (med 15)
HK1035717A1 (en) New crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester (med 15)
JPS62242667A (ja) ベンジルイソキノリン誘導体